These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Prognostic Value of Electrocardiographic Left Ventricular Hypertrophy on Cardiovascular Risk in a Non-Hypertensive Community-Based Population. Tanaka K, Tanaka F, Onoda T, Tanno K, Ohsawa M, Sakata K, Omama S, Ogasawara K, Ishibashi Y, Itai K, Kuribayashi T, Okayama A, Nakamura M, Iwate-Kenco Study Group. Am J Hypertens; 2018 Jul 16; 31(8):895-901. PubMed ID: 29659657 [Abstract] [Full Text] [Related]
28. [Prevalence of left ventricular hypertrophy, atrial fibrillation and cardiovascular disease in hypertensive patients of Andalusia, Spain. PREHVIA study]. Martín-Rioboó E, García Criado E, Pérula De Torres LA, Cea-Calvo L, Anguita Sánchez M, López Granados A, Ureña Fernández T, García Matarín L, Molina Díaz R, en representación del Grupo de Hipertensión Arterial de la Sociedad Andaluza de Medicina Familiar y Comunitaria (SAMFyC) y de los investigadores del estudio PREHVIA. Med Clin (Barc); 2009 Feb 28; 132(7):243-50. PubMed ID: 19248873 [Abstract] [Full Text] [Related]
29. P-wave duration and the risk of atrial fibrillation: Results from the Copenhagen ECG Study. Nielsen JB, Kühl JT, Pietersen A, Graff C, Lind B, Struijk JJ, Olesen MS, Sinner MF, Bachmann TN, Haunsø S, Nordestgaard BG, Ellinor PT, Svendsen JH, Kofoed KF, Køber L, Holst AG. Heart Rhythm; 2015 Sep 28; 12(9):1887-95. PubMed ID: 25916567 [Abstract] [Full Text] [Related]
30. Qt dispersion and mortality in the elderly. Perkiömäki JS, Sourander LB, Levomäki L, Räihä IJ, Puukka P, Huikuri HV. Ann Noninvasive Electrocardiol; 2001 Jul 28; 6(3):183-92. PubMed ID: 11466135 [Abstract] [Full Text] [Related]
39. The association of QT interval components with atrial fibrillation. Patel N, O'Neal WT, Whalen SP, Soliman EZ. Ann Noninvasive Electrocardiol; 2018 Mar 28; 23(2):e12467. PubMed ID: 28660734 [Abstract] [Full Text] [Related]